TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publications
about
CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapyReplication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer.Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in Chinese women nonsmokers.A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects.Genetic variant rs401681 at 5p15.33 modifies susceptibility to lung cancer but not esophageal squamous cell carcinomaAssociation between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer.Association of epidermal growth factor receptor (EGFR) gene polymorphism with lung cancer risk: a systematic review.Genetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males.Quantifying the Genetic Correlation between Multiple Cancer Types.CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma.CRR9p polymorphism as a protective factor for lung cancer.Population-specific association of genes for telomere-associated proteins with longevity in an Italian population.
P2860
Q34394189-04B70AE5-ADB0-47C6-8EE5-31881A919BA2Q34557311-59B1A72F-7962-4FD2-930B-7B9962B93E40Q34709908-A090346F-0BE3-4AE1-BF59-E9119F6B1828Q34758997-4EEC0A85-F185-4D95-BE91-98928C6E25E7Q35000534-92380C06-3161-4186-9B68-708C2F16F025Q35080890-AFBF6AE5-C93C-4DBD-80BD-8116483C9297Q35652709-A520898C-4F24-4C85-AD46-3E8697837E01Q36918144-C17BEFAD-8AF7-4810-9F1E-B397FCA0A28FQ37705870-DD7EF667-6A47-4E95-BB2C-D43B4402DD42Q38185151-45E1E003-C58C-4E30-964E-EF32A7A7639EQ38633674-CF39450D-5928-4698-92AE-F7E4FC32E541Q38668303-468F4F7A-06E6-4C49-9AD9-9A182373405DQ39068532-14F5B583-7785-4822-9D8D-AF75FED233AEQ42373181-379B806A-2676-4EF4-9B35-D5179D460D84Q43433954-738DD1B5-0EC2-46DC-8F3A-88A803D23F9AQ51373775-18508ED8-ACF5-4439-97CB-73C4D69B6E8A
P2860
TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publications
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@ast
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@en
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@nl
type
label
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@ast
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@en
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@nl
prefLabel
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@ast
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@en
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@nl
P2093
P2860
P1433
P1476
TERT-CLPTM1L polymorphism rs40 ...... lysis based on 29 publications
@en
P2093
Jieyun Yin
Jingwen Sun
Shaofa Nie
Xiaorong Li
Yangkai Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0050650
P407
P577
2012-01-01T00:00:00Z